Varsha Gandhi

PROMISE: a tool to identify genomic features with a specific biologically interesting pattern of associations with multiple endpoint variables

Cheng Cheng, Stan Pounds, Xueyuan Cao, 2009, Bioinform..

Ibrutinib and Venetoclax for First-Line Treatment of CLL.

Naveen Garg, Rashmi Kanagal-Shamanna, Prithviraj Bose, 2019, The New England journal of medicine.

MET receptor tyrosine kinase as a therapeutic anticancer target.

Varsha Gandhi, C. M. Stellrecht, V. Gandhi, 2009, Cancer letters.

Mechanisms of cytotoxicity to Pim kinase inhibitor, SGI-1776, in acute myeloid leukemia.

Varsha Gandhi, J. Cortes, Lisa S. Chen, 2011, Blood.

Interim comparison of a continuous infusion versus a short daily infusion of cytarabine given in combination with cladribine for pediatric acute myeloid leukemia.

Deo Kumar Srivastava, Ching-Hon Pui, Varsha Gandhi, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

Michael Peyton, John D. Minna, Li Shen, 2012, Clinical Cancer Research.

Novel purine nucleoside analogues for T-cell-lineage acute lymphoblastic leukaemia and lymphoma

Varsha Gandhi, F. Ravandi, V. Gandhi, 2006, Expert opinion on investigational drugs.

Intracellular Succinylation of 8-Chloroadenosine and Its Effect on Fumarate Levels*

Varsha Gandhi, William Plunkett, Jennifer B Dennison, 2010, The Journal of Biological Chemistry.